Tempus will use its recently launched Tempus O informatics platform to collect and structure clinical data from VICC's electronic health records.
The Vanderbilt Center for Undiagnosed Diseases will use FDNA's Face2Gene to help evaluate difficult-to-diagnose patients.
The Universal Influenza Vaccine Initiative, led by Vanderbilt and the Human Vaccines Project, has turned to omics and AI to create more effective flu vaccines.
Living DNA and its partners are aiming to create a detailed genetic map of the world based on people's DNA.
The partners will integrate genomic analyses and de-identified clinical data into Goldfinch's genomic registry of kidney disease patients.
Bioinformatics and genomic medicine stand to have outsize influence in the the new, university-wide Vanderbilt Data Science Visions Working Group.
The head of the data center for the Precision Medicine Initiative's All of Us program discusses plans to manage records on 1 million people from dozens of sites.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
An international team of researchers has mapped new associations between HLA mutations and specific diseases, and made their data freely accessible.
Illumina's partnership with the Human Vaccines Project and Vanderbilt looks to crunch data sets billions of times larger than human genome.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.